Psychosoziale Faktoren

  • M. Wolfersdorf
  • A. Heindl
  • B. Schuh
  • J. Kornacher
  • U. Rupprecht
  • F. Keller

Zusammenfassung

Das Fehlen sozialer Unterstützung und sozialer Bindungen ist besonders mit Therapieresistenz verbunden. Daneben sind auch vorausgehende und interkurrente Stress-Situationen durch belastende Lebensereignisse bedeutsam. Die Behandlung therapieresistenter bzw. chronischer depressiver Erkrankungen hat sich auf folgende Ziele auszurichten:
  • stabile psychopharmakologische Symptomminimierung und Verschlechterungsprophylaxe,

  • eine unter psychotherapeutisch-sozialpsychiatrischer Begleitung/Behandlung erworbene neue Lebenskonzeption.

Die langfristige Begleitung ist gekennzeichnet durch Regelmäßigkeit, Kontinuität, Verlässlichkeit, bei Bedarf Krisenintervention und praktische Unterstützung. Die Behandlung therapieresistenter chronisch-depressiver Kranker bedarf schulenübergreifender überlegungen und Kompetenz sowie der Supervision und Selbsterfahrung.

Literatur

  1. Bagby RM, Ryder AG, Cristi C (2002) Psychosocial and clinical predictors of response to pharmacotherapy for depression. Rev Psychiatr Neurosci 27: 250–257Google Scholar
  2. Brown GW, Harris T (1978) Social origins of depression: a study of psychiatric disorders in women. Tavistock, LondonGoogle Scholar
  3. Brown GW, Harris T (1986) Establishing causal links: the Bedford College studies of depression. In: Katschnig H (ed) Life events and psychiatric disorders: controversial issues. Cambridge University Press, pp 107–187Google Scholar
  4. Ezquiaga E, Garcia A, Bravo F, Pallares T (1989) Factors associated with outcome in major depression: a 6-month prospective study. Soc Psychiatry Psychiatr Epidemiol 33: 552–557CrossRefGoogle Scholar
  5. Hammen C, Adrian C, Hiroto D (1988) A longitudinal test of the attributional vulnerability model in children at risk for depression. Br J Clin Psychol 27: 37–46PubMedGoogle Scholar
  6. Heim C, Nemeroff CB (2001) The role of childhood trauma in the neurobiology of mood and anxiety disorders: preclinical and clinical studies. Biol Psychiatry 49: 1023–39CrossRefPubMedGoogle Scholar
  7. Hirschfeld RM, Russel JM, Delgado PL, Fawcett J, Friedman RA, Harrison WM et al. (1998) Predictors of response to acute treatment of chronic and double depression with sertraline or imipramine. J Clin Psychiatry 59: 669–675PubMedGoogle Scholar
  8. Joyce PR, Mulder RT, Cloninger CR (1994) Temperament predicts clomipramine and desipramine response in major depression. J Affect Disord 30: 35–46CrossRefPubMedGoogle Scholar
  9. Katschnig H, Nutzinger DO (1988) Psychosocial aspects of course and outcome in depressive illnes. In: Helgason T, Daly RJ (eds) Depressive illness. Prediction of course and outcome. Springer, Berlin Heidelberg New York Tokio, pp 63–89Google Scholar
  10. Keller F (1997) Belastende Lebensereignisse und der Verlauf von Depressionen. Waxmann, MünsterGoogle Scholar
  11. Keller MB (2003) Past, present, and future directions of defining optimal treatment outcome in depression: remission and beyond. JAMA 289: 3152–3160CrossRefPubMedGoogle Scholar
  12. Keller MB, McCullongh JP, Klein DN et al. (2000) A comparison of nefazodon, a cognitive behavioral analysis system of psychotherapy, and their combination for the treatment of chronic depression. N Engl J Med 342: 1462–1470CrossRefPubMedGoogle Scholar
  13. Kendler KS, Thornton LM, Gardner CO (2000) Stressful life events and previous episodes in the etiology of major depression in women: an evaluation of the »kindling« hypothesis. Am J Psychiatr 157: 1243–1251CrossRefPubMedGoogle Scholar
  14. Lehmann H, Fenton F, Deutsch M, Feldman S, Engelsmann F (1988) An 11-year follow up study of 110 depressed patients. Acta Psychiatr Scand 78: 57–65PubMedGoogle Scholar
  15. Luborsky I, Digner I, Cacciola J, Barber JP, Moras K, Schmidt K, De-Rubeis RJ (1996) Factors in outcomes of short-term dynamic psychotherapy for chronic versus non-chronic major depression. J Psychotherapy 5: 152–159Google Scholar
  16. Miller IW, Keitner GI, Schatzberg AF et al. (1998) The treatment of chronic depression, part 3: psychosocial functioning before and after treatment with sertraline or imipramine. J Clin Psychiatry 59: 608–619PubMedGoogle Scholar
  17. Monroe SM, Simons AD, Thase ME (1992) Social factors and the psychobiology of depression: relations between life stress and rapid eye movement sleep latency. J Abnorm Psychol 101: 528–537PubMedGoogle Scholar
  18. Mundt C (1996) Psychotherapy of depressive disorders: on theoretical background and practice relevance. Nervenarzt 67: 183–197Google Scholar
  19. Mundt C (1998) Psychopathologische und psychosoziale Frühindikationen depressiver Erkrankungen. In: Klosterkötter J (Hrsg) Frühdiagnostik und Frühbehandlung psychischer Störungen. Springer, Berlin Heidelberg New York Tokio, S 171–181Google Scholar
  20. Mundt C, Reck C, Backenstrass M, Kronmuller K, Fiedler P (2000) Reconfirming the role of life events for the timing of depressive episodes. A two-year prospective follow-up study. J Affect Disord 59: 23–30CrossRefPubMedGoogle Scholar
  21. Mundt C, Reck C, Backenstrass M, Kronmüller K, Fiedler P (2000) Reconfiming the role of life events for the timing of depressive episodes. A two-year prospective follow-up study. J Aff Disord 59: 23–30CrossRefGoogle Scholar
  22. Nolen-Hoeksema S, Parker L, Larson J (1994) Ruminative coping with depressed mood following loss. J Personality Social Psychol 76: 92–104CrossRefGoogle Scholar
  23. Paykel ES, Ramana R, Cooper Z, Hayhurst H, Kerr J, Barocka A (1995) Residual symptoms after partial remission. An important outcome in depression. Psychol Med 25: 1171–1180PubMedGoogle Scholar
  24. Paykel ES, Tanner J (1976) Life events, depressive relapse and maintenance treatment. Psycho Med 6: 481–485Google Scholar
  25. Prince M, Harwood R, Thomas A, Mann A (1998) Prospective population-based cohort study of the effects of disablement and social milieu on the onset and maintenance of late-life depression. The Gospel Oak project VII. Psychol Med 28: 337–350CrossRefPubMedGoogle Scholar
  26. Reno RM, Halaris (1990) The relationship between life stress and depression in an endogenous sample. Comp Psychiatry 31: 25–33CrossRefGoogle Scholar
  27. Ruppe A (1996) Langzeitverlauf von Depressionen. Ergebnisse einer prospektiven 6-Jahreskatamnese. Roderer, RegensburgGoogle Scholar
  28. Simon GE, Revicki D, Heiligenstein J et al. (2000) Recovery from depression, work productivity and health care costs among primary care patients. Gen Hosp Psychiatry 22: 153–162CrossRefPubMedGoogle Scholar
  29. Swindle R, Cronkite R, Moos R (1989) Life stressors, social resources, coping, and the 4-year course of unipolar depression. J Abnorm Psychol 98: 468–477CrossRefPubMedGoogle Scholar
  30. Tennant C (2002) Life events, stress, and depression: A review of recent findings. Aust NZ J Psychiatr 36: 173–182CrossRefGoogle Scholar
  31. Thase ME, Friedman ES, Howland RH (2001) Management of treatment-resistant depression: psychotherapeutic perspectives. J Clin Psychiatry 62: 18–24Google Scholar
  32. Trivedi MH, Kleiber BA (2001) Algorithm for the treatment of chronic depression. J Clin Psychiatry 62[Suppl 6]: 22–29Google Scholar
  33. Weig W (2002) Psychiatrische Rehabilitation. In: Möller HJ, Laux G, Kapfhammer HP (Hrsg) Psychiatrie und Psychotherapie. Springer, Berlin Heidelberg New York TokioGoogle Scholar
  34. Wildes JE, Harkness KL, Simons AD (2002) Life events, number of social relationships, and twelf-month naturalistic course of major depression in a community sample of women. Depress Anxiety 16: 104–113PubMedGoogle Scholar
  35. Wolfersdorf M, Heindl A (2003) Chronische Depression. Pabst, GüterslohGoogle Scholar
  36. Wolfersdorf M, Keller F, Ruppe A, Zimmermann U, Grünewald I, Köng F (1998) Prävention bei depressiven Störungen — psychosoziale Aspekte in der Primär-, Sekundär-und Tertiärprävention. In: Klosterkötter J (Hrsg) Frühdiagnostik und Frühbehandlung psychischer Störungen. Springer, Berlin Heidelberg New York Tokio, S 185–203Google Scholar
  37. Wolfersdorf M, Keller F, Steiner B, Hautzinäger M, Hole G (1990) Psychosoziale Faktoren als Risiko für Therapieresistenz auf Antidepressiva. In: Möller H-J (Hrsg) Therapieresistenz unter Antidepressiva-Behandlung. Springer, Berlin Heidelberg New York Tokio, S 191–215Google Scholar

Copyright information

© Springer Medizin Verlag Heidelberg 2005

Authors and Affiliations

  • M. Wolfersdorf
  • A. Heindl
  • B. Schuh
  • J. Kornacher
  • U. Rupprecht
  • F. Keller

There are no affiliations available

Personalised recommendations